Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Elevai Labs, Inc. - Common Stock (NQ: ELAB ) 0.0852 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Oct 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Elevai Labs, Inc. - Common Stock < Previous 1 2 3 Next > Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Launch of Clinical Study Combining Its Flagship Topical Exosome Skincare Products with a Medical Aesthetic Energy Device October 02, 2024 From Elevai Labs Inc. Via GlobeNewswire 7 Penny Stocks to Watch Now: ELAB, RJDG, BTTC, ATCH, CBDW, and More! September 25, 2024 Via AB Newswire Dow Gains Over 50 Points; Elevai Labs Shares Plummet September 23, 2024 Via Benzinga Topics Stocks Exposures US Equities Crude Oil Down Over 1%; US Manufacturing PMI Falls In September September 23, 2024 Via Benzinga Exposures Fossil Fuels Why Elevai Labs (ELAB) Stock Is Down 60% Today September 23, 2024 Elevai Labs shares are trading lower by 60% Monday morning. The company announced the pricing of an $8.0 million public offering. Via Benzinga ELAB Stock Earnings: Elevai Labs Reported Results for Q2 2024 August 14, 2024 Elevai Labs just reported results for the second quarter of 2024. Via InvestorPlace ELAB Stock Earnings: Elevai Labs Reported Results for Q1 2024 May 15, 2024 Elevai Labs just reported results for the first quarter of 2024. Via InvestorPlace US Stocks Edge Higher; Chicago Fed National Activity Increases In August September 23, 2024 Via Benzinga Topics Economy Exposures Interest Rates Elevai Labs Inc. Announces Pricing of $8.0 Million Public Offering September 23, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Results for E-Series Exosome Technology in Potential Melasma Applications September 10, 2024 From Elevai Labs Inc. Via GlobeNewswire Why GitLab Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket September 04, 2024 Via Benzinga Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Encouraging Data Results Indicating Potential for Hair Restoration Using Proprietary Exosome Technology September 03, 2024 From Elevai Labs Inc. Via GlobeNewswire 12 Consumer Staples Stocks Moving In Monday's After-Market Session September 02, 2024 Via Benzinga Elevai Labs Inc. Files Combination Patents with Yuva Biosciences for Breakthrough Hair and Scalp Care Technology Utilizing YuvaBioⓇ Y100™ Mitochondrial Innovation and Elevai Exosomes™ August 28, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Labs Inc. Subsidiary, Elevai Skincare Inc., Announces Positive Data Results with Completion of Clinical Study of Elevai Enfinity™ Topical Exosome Serum August 26, 2024 From Elevai Labs Inc. Via GlobeNewswire Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket August 26, 2024 Via Benzinga Why Workday Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket August 23, 2024 Via Benzinga Elevai Labs Inc. Subsidiary, Elevai Research Inc., Announces Preliminary Positive Research Data Highlighting the Potential of Proprietary Exosome Technology for Skin Health Applications August 19, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Labs Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update August 14, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Labs Inc. Subsidiary, Elevai Biosciences, Continues to Advance its Scientific Advisory Board with the Appointment of Orian Shirihai, MD, PhD July 30, 2024 From Elevai Labs Inc. Via GlobeNewswire Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket July 25, 2024 Via Benzinga Top 4 Risk Off Stocks You'll Regret Missing In July July 16, 2024 Via Benzinga Elevai Labs Inc. Subsidiary, Elevai Skincare, Announces The Elevai S-Series Hair and Scalp Care Product Line June 28, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Labs Inc. Subsidiary, Elevai Skincare to Debut Upcoming New Product Line at The Aesthetic Show 2024 June 26, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Labs Forms New Scientific Advisory Board for its Weight Loss Programs June 14, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Labs Subsidiary, Elevai Skincare, to Present at the Beauty Through Science Conference in Stockholm May 29, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Labs Inc Subsidiary, Elevai Biosciences, to Present at the UCLA LA-BEST 2024 Conference May 22, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Labs (NASDAQ: ELAB) Acquires Rights To Develop Muscle Loss Prevention Assets For Anticipated Use In Anti-Obesity Treatments, Launches Two New Subsidiaries May 17, 2024 Elevai Labs (NASDAQ: ELAB) Acquires Rights To Develop Muscle Loss Prevention Assets For Anticipated Use In Anti-Obesity Treatments, Launches Two New Subsidiaries Via News Direct Elevai Labs Inc. Reports First Quarter 2024 Financial Results May 15, 2024 From Elevai Labs Inc. Via GlobeNewswire Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity May 02, 2024 From Elevai Labs Inc. Via GlobeNewswire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.